Merck & Co. Inc. buy UBS Group AG
Start price
02.02.24
/
50%
€117.60
Target price
02.02.25
€137.06
Performance (%)
-12.15%
Price
26.09.24
€101.20
Summary
This prediction is currently active. The prediction for Merck & Co. Inc. disappoints with a performance of -12.15%. Dividends of €2.12 are taken into consideration when calculating the performance. This prediction currently runs until 02.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | -3.619% | -3.619% |
iShares Core DAX® | 1.518% | 3.456% |
iShares Nasdaq 100 | 1.240% | 2.983% |
iShares Nikkei 225® | 2.808% | 2.743% |
iShares S&P 500 | 0.403% | 2.187% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at UBS Group AG from $135.00 to $148.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.36
31.07.25
31.07.25
-2.59%
26.09.24
26.09.24